Long-term efficacy and safety of fenofibrate and a statin in the treatment of combined hyperlipidemia.

@article{Ellen1998LongtermEA,
  title={Long-term efficacy and safety of fenofibrate and a statin in the treatment of combined hyperlipidemia.},
  author={R L Ellen and Ruth Mcpherson},
  journal={The American journal of cardiology},
  year={1998},
  volume={81 4A},
  pages={60B-65B}
}
To assess the long-term efficacy and use of fenofibrate together with a 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor ("statin") in the treatment of elevated levels of triglycerides and low-density lipoprotein (LDL) cholesterol, we conducted a study that compared a before- and after-case series. The study involved 80 patients with a diagnosis of combined hyperlipidemia and existing coronary artery disease (81% of patients) or outpatients with > or = 3 risk factors for… CONTINUE READING